Clinical trial
A Phase 1 Clinical Trial of Autologous iPSC-Derived Dopamine Neuron Transplantation for Parkinson's Disease
NCT06422208 is registered in ClinicalTrials.gov with Penelope J. Hallett, Ph.D. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Clinical Trial of Autologous iPSC-Derived Dopamine Neuron Transplantation for Parkinson's Disease
- Lead sponsor
- Penelope J. Hallett, Ph.D.
- Phase
- Phase 1
- Overall status
- Enrolling by invitation
- Start date
- August 7, 2024
- Completion date
- December 31, 2028
- Enrollment
- 12 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.